EcoDrugPlus

Estrogen Receptor 2

Ensembl ID : ENSMMDG00005020155
Gene Symbol: ESR2
3 Cross references
198 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSMMDG00005013970
Gene Symbol: LOC115354622
3 Cross references
210 Possible Orthologues:

Estrogen Receptor-Like

Ensembl ID : ENSMMDG00005004992
Gene Symbol: LOC115356071
3 Cross references
215 Possible Orthologues:

Estrogen-Related Receptor Gamma A

Ensembl ID : ENSMMDG00005019455
Gene Symbol: ESRRGA
1 Cross references
198 Possible Orthologues:

Exportin 1

Ensembl ID : ENSMMDG00005011834
Gene Symbol: XPO1
3 Cross references
224 Possible Orthologues:

Exportin 1

Ensembl ID : ENSMMDG00005008572
Gene Symbol: XPO1
3 Cross references
213 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSMMDG00005016653
Gene Symbol: FDPS
3 Cross references
267 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSMMDG00005023104
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSMMDG00005015061
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSMMDG00005016898
Gene Symbol: FGFR1
3 Cross references
209 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSMMDG00005009617
Gene Symbol: FGFR1
3 Cross references
204 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSMMDG00005007887
Gene Symbol: FGFR2
1 Cross references
218 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).